Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Bill Wexler's Dog Pound -- Ignore unavailable to you. Want to Upgrade?

To: JDN who wrote (3942)	9/23/1999 8:43:00 AM
From: DanZ	Respond to of 10293

JDN, Thanks for the feedback. The head buyer at Albertsons told me much the same thing about Zicam when I spoke to him a few months ago. He even used it himself before placing it in the chain. My view on GUMM from a chart perspective. Support 11 to 11 1/4. Bounce from there back to test 14 to 15. Spike on publication in a medical journal, albeit maybe not the NEJM. Further spike on news of a joint venture with a large multinational firm to manufacture and distribute nicotine gum worldwide. They aren't just going after the nicotine cessation market; they are also going after the nicotine market ($46 billion industry). Best of luck, Dan